CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

RPG LIFE SCIENCES LTD.

NSE : RPGLIFEBSE : 532983ISIN CODE : INE105J01010Industry : Pharmaceuticals & DrugsHouse : RPG Enterprises
BSE2580.75-30.95 (-1.19 %)
PREV CLOSE () 2611.70
OPEN PRICE () 2640.00
BID PRICE (QTY) 2579.25 (7)
OFFER PRICE (QTY) 2587.85 (7)
VOLUME 3979
TODAY'S LOW / HIGH ()2521.90 2673.90
52 WK LOW / HIGH ()1210 2649.8
NSE2565.45-43.75 (-1.68 %)
PREV CLOSE() 2609.20
OPEN PRICE () 2621.95
BID PRICE (QTY) 2566.05 (1)
OFFER PRICE (QTY) 2570.45 (2)
VOLUME 37472
TODAY'S LOW / HIGH() 2510.05 2680.00
52 WK LOW / HIGH ()1225.05 2650
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2007

Management Info :

Harsh Goenka - Chairman Yugal Sikri - Managing Director

Registered Office :

Address : R P G House , 463,Ceat Mahal,Dr. Annie Besant Road, Worli,
Mumbai,
Maharashtra-400030

Phone : 022 - 24981650 / 24986375

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
08Aug Rpg Life Sciences informs about analys
Pursuant to Regulation 30 read with Para A of Schedule Ill of the SEBI (..
20Jul Rpg Life Sciences informs about press
Rpg Life Sciences has informed that it enclosed a copy of press release..
12Mar RPG Life Sciences signs Share Subscrip
RPG Life Sciences has signed Share Subscription and Shareholders' agreem..
20Dec RPG Life Sciences informs about detail
RPG Life Sciences has enclosed intimation of the loss of share certifica..
19Oct RPG Life Sciences to execute power del
RPG Life Sciences has received approval for execution of Power Delivery..
Financials
in Millions
QTR Jun 24 ANNUAL 24
Net Profit267.6876.6
Gross Profit 360 1178.4
Operating Profit 414.41353.6
Net Sales 1654.25820.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 7799.30 (4.94%)
M.Cap ( in Cr)
19440.00
Dr. Reddy's Lab (BSE)
 6680.00 (0.67%)
M.Cap ( in Cr)
111265.20
SMS Lifesciences (BSE)
 1475.00 (1.12%)
M.Cap ( in Cr)
445.93
Cipla (BSE)
 1632.75 (0.61%)
M.Cap ( in Cr)
131383.07
Fredun Pharma (BSE)
 810.00 (1.15%)
M.Cap ( in Cr)
384.84
Shareholding Pattern
PROMOTERS 72.81%
NON-INSTITUTION 23.43%
MUTUAL FUNDS/UTI 1.65%
FI/BANKS/INSURANCE 0.52%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX81468.43-220.02 (-0.27%)
NIFTY24900.15-114.45 (-0.46%)
Dow Jones 42352.75341.16 (0.81%)
Nasdaq 18137.85219.37 (1.22%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI